702 filings
Page 26 of 36
CORRESP
mbdyhlzk c7l1hg1t
31 Jan 11
Correspondence with SEC
12:00am
CORRESP
l98stqcnmfxyvr75ftk
25 Jan 11
Correspondence with SEC
12:00am
8-K
cka514eqv h2gatg
21 Jan 11
Other Events
12:00am
8-K
s3rqw3 zqlax7xiygx
10 Jan 11
Acorda Therapeutics To Provide Business Update Today at J.P. Morgan Healthcare Conference
12:00am
8-K
sfe8cn
9 Dec 10
Other Events
12:00am
8-K
22vjl kkrsg1
17 Nov 10
Additional Phase 3 Clinical Trial Data Published in Annals of Neurology Showing Dalfampridine
12:00am
CORRESP
8hpf94
9 Nov 10
Correspondence with SEC
12:00am
8-K
vn7zl49egxya r9gzp
1 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
y2wuakrb0 5dx4o4p
19 Oct 10
Other Events
12:00am
8-K
d59fidrw 9m5
15 Oct 10
Other Events
12:00am
CORRESP
xruwunm1so
27 Aug 10
Correspondence with SEC
12:00am
UPLOAD
yc28xz6acq241y8rr93f
10 Aug 10
Letter from SEC
12:00am
8-K
fsndb5 e98
3 Aug 10
Results of Operations and Financial Condition
12:00am
8-K
p8cy248x
20 Jul 10
Acorda Therapeutics Announces Receipt of NIH Grant for Development of GGF2 in Heart Failure
12:00am
8-K
r5xbmar 6ur39s
7 Jul 10
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
12:00am
8-K
ybu8du
25 Jun 10
Other Events
12:00am
8-K
ty6rd 7qpl33jyruyx4
11 Jun 10
Submission of Matters to a Vote of Security Holders
12:00am